GSK CEO: Drug Discovery, AI in Pharma, and Changing Company Culture
In Good Company with Nicolai Tangen
Exploring the Future of Combination Vaccines for the Elderly
This chapter explores the challenges and potential of developing combination vaccines that can address multiple diseases for the elderly, including flu, COVID, shingles, and pneumonia. It discusses the role of mRNA technology in revolutionizing vaccine creation and the considerations needed for long-lasting efficacy.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
